INSPIRE MEDICAL SYSTEMS INC (INSP) Forecast, Price Target & Analyst Ratings

NYSE:INSP • US4577301090

Current stock price

54.04 USD
+0.4 (+0.75%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INSPIRE MEDICAL SYSTEMS INC (INSP).

Forecast Snapshot

Consensus Price Target

Price Target
$91.79
+ 69.85% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
206.55M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
73.60%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$91.79
Upside
+ 69.85%
From current price of $54.04 to mean target of $91.79, Based on 25 analyst forecasts
Low
$60.60
Median
$78.03
High
$189.00

Price Target Revisions

1 Month
-3.94%
3 Months
-36.40%

Price Target Summary

25 Wall Street analysts provided a forecast for the next 12 months for INSP. The average price target is 91.79 USD. This implies a price increase of 69.85% is expected in the next year compared to the current price of 54.04.
The average price target has been revised downward by 36.4% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

INSP Current Analyst RatingINSP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

INSP Historical Analyst RatingsINSP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20 25

Analyst Ratings Consensus

ChartMill Buy Consensus
73.60%
INSP was analyzed by 25 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about INSP.
In the previous month the buy percentage consensus was at a similar level.
INSP was analyzed by 25 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05StifelMaintains Buy -> Buy
2026-02-13Wolfe ResearchDowngrade Outperform -> Peer Perform
2026-02-12MizuhoMaintains Outperform -> Outperform
2026-02-12RBC CapitalMaintains Sector Perform -> Sector Perform
2026-02-12Wells FargoDowngrade Overweight -> Equal-Weight
2026-02-12Truist SecuritiesMaintains Hold -> Hold
2026-02-12BairdDowngrade Outperform -> Neutral
2026-02-12Piper SandlerMaintains Overweight -> Overweight
2026-02-12JefferiesMaintains Hold -> Hold
2026-01-27RBC CapitalDowngrade Outperform -> Sector Perform
2026-01-14Wells FargoMaintains Overweight -> Overweight
2026-01-08Truist SecuritiesMaintains Buy -> Buy
2025-12-23UBSMaintains Neutral -> Neutral
2025-12-17MizuhoMaintains Outperform -> Outperform
2025-12-17RBC CapitalMaintains Outperform -> Outperform
2025-12-16JP MorganMaintains Neutral -> Neutral
2025-12-08OppenheimerUpgrade Perform -> Outperform
2025-12-08Piper SandlerMaintains Overweight -> Overweight
2025-12-04BairdMaintains Outperform -> Outperform
2025-12-02Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-11-26Truist SecuritiesUpgrade Hold -> Buy
2025-11-25Wolfe ResearchUpgrade Peer Perform -> Outperform
2025-11-24StifelUpgrade Hold -> Buy
2025-11-04RBC CapitalMaintains Outperform -> Outperform
2025-11-04Wells FargoUpgrade Equal-Weight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.27
Revenue Estimate
206.55M
Revenue Q2Q
2.60%
EPS Q2Q
-365.08%
Number of Analysts
19

Next Earnings Revisions

Revenue (1 Month)
-0.82%
Revenue (3 Months)
-5.59%
EPS (1 Month)
-16.09%
EPS (3 Months)
-389.75%

Next Earnings Summary

INSP is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.27 USD and the consensus revenue estimate is 206.55M USD.
The next earnings revenue estimate has been revised downward by 5.59% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
INSP revenue by date.INSP revenue by date.
624.799M
53.17%		802.804M
28.49%		911.981M
13.60%		986.73M
8.20%		1.07B
8.44%		1.182B
10.47%		1.315B
11.25%		1.448B
10.11%		1.506B
4.01%		1.656B
9.96%		1.701B
2.72%
EBITDA
YoY % growth
INSP ebitda by date.INSP ebitda by date.
-37.425M
18.18%		42.633M
213.92%		64.911M
52.26%		226.99M
249.69%		266.98M
17.62%		267.78M
0.30%		353.79M
32.12%		411.06M
16.19%		461.04M
12.16%		N/AN/A
EBIT
YoY % growth
INSP ebit by date.INSP ebit by date.
-40.271M
15.40%		36.083M
189.60%		50.954M
41.21%		63.662M
24.94%		85.535M
34.36%		112.82M
31.90%		160.92M
42.63%		206.99M
28.63%		313.6M
51.50%		479.4M
52.87%		559.98M
16.81%
Operating Margin
INSP operating margin by date.INSP operating margin by date.
-6.45%4.49%5.59%6.45%7.99%9.54%12.24%14.29%20.82%28.95%32.92%
EPS
YoY % growth
INSP eps by date.INSP eps by date.
-0.74
54.88%		1.73
333.78%		2.51
45.09%		1.97
-21.33%		2.59
30.97%		3.53
36.43%		4.65
31.67%		5.82
25.36%		6.45
10.68%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		-0.27
-365.08%		0.29
-35.80%		0.51
51.13%		1.45
-10.58%		0.14
153.87%		0.48
67.45%		0.64
24.77%		1.21
-16.20%		0.52
264.29%		0.73
51.81%		0.75
17.73%		0.90
-26.05%
Revenue
Q2Q % growth		206.55M
2.60%		234.62M
8.08%		247.67M
10.32%		299.31M
11.24%		229.85M
11.28%		252.38M
7.57%		264.7M
6.88%		316.85M
5.86%		255.66M
11.23%		281.81M
11.66%		295.02M
11.45%		358.39M
13.11%
EBITDA
Q2Q % growth		24.376M
1,463.57%		51.23M
1,530.49%		52.744M
166.67%		92.135M
53.38%		100.23M
311.18%		48.28M
-5.76%		52.972M
0.43%		68.374M
-25.79%		24.286M
-75.77%		33.517M
-30.58%		35.088M
-33.76%		40.463M
-40.82%
EBIT
Q2Q % growth		-13.703M
-822.75%		7.664M
331.12%		16.182M
67.79%		50.595M
9.72%		-2.304M
83.19%		12.606M
64.48%		20.46M
26.44%		50.86M
0.52%		17.901M
877.10%		26.775M
112.40%		28.03M
37.00%		34.048M
-33.06%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.02%
EPS Next 5 Year
18.33%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.46%
Revenue Next 5 Year
9.35%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
109.90%
EBIT Next 5 Year
69.99%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

INSPIRE MEDICAL SYSTEMS INC / INSP Forecast FAQ

What is the average price target for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

25 analysts have analysed INSP and the average price target is 91.79 USD. This implies a price increase of 69.85% is expected in the next year compared to the current price of 54.04.

Can you provide the upcoming earnings date for INSPIRE MEDICAL SYSTEMS INC?

INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2026-05-04, after the market close.

What are the consensus estimates for INSP stock next earnings?

The consensus EPS estimate for the next earnings of INSPIRE MEDICAL SYSTEMS INC (INSP) is -0.27 USD and the consensus revenue estimate is 206.55M USD.

How many analysts have analysed INSPIRE MEDICAL SYSTEMS INC (INSP)?

The number of analysts covering INSPIRE MEDICAL SYSTEMS INC (INSP) is 25.